Condition: Immune Thrombocytopenic Purpura (ITP) · Sponsor: Takeda
Primary immune thrombocytopenia (ITP) is a condition where the immune system mistakenly destroys platelets, which are cells that help stop bleeding. This leads to a lower number of platelets, making it easier to bruise or bleed. The main aim of this study is to check how safe mezagitamab is and how well it is tolerated by adults with chronic primary ITP, if given over a longer time. Other aims are to learn how effective treatment with mezagitamab is and how the body processes it (called pharmacokinetics or PK) over a longer time. Participants of the following previous mezagitamab studies will be invited to join this continuation study: TAK-079-3002 and TAK-079-1004. In this continuation study, participants will receive mezagitamab when certain protocol criteria are met. During the study, participants will visit their study clinic several times.
This description comes directly from the study's public registry record.
Takeda Contact · +1-877-825-3327 · medinfoUS@takeda.com
Always discuss trial participation with your own doctor first.
| USC Norris Comprehensive Cancer Center - Keck Medicine of USC | Los Angeles, California, United States | Not Yet Recruiting |
| Rocky Mountain Cancer Center | Denver, Colorado, United States | Withdrawn |
| Georgetown University Medical Center - Lombardi Comprehensive Cancer Center | Washington D.C., District of Columbia, United States | Not Yet Recruiting |
| Emory University | Atlanta, Georgia, United States | Not Yet Recruiting |
| The University of Iowa | Iowa City, Iowa, United States | Not Yet Recruiting |
| University Of Louisville Brown Cancer Center | Louisville, Kentucky, United States | Not Yet Recruiting |
| Massachusetts General Hospital | Boston, Massachusetts, United States | Recruiting |
| University of Massachusetts Chan Medical School | Worcester, Massachusetts, United States | Not Yet Recruiting |
| Duke University Hospital | Durham, North Carolina, United States | Not Yet Recruiting |
| East Carolina University | Greenville, North Carolina, United States | Not Yet Recruiting |
| Oregon Health & Science University | Portland, Oregon, United States | Not Yet Recruiting |
| Perelman Center for Advanced Medicine (PCAM) Hospital of The University of Pennsylvania Penn Blood Disorders Program | Philadelphia, Pennsylvania, United States | Not Yet Recruiting |
+ 97 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06948318